PRRT2 mutations are related to febrile seizures in epileptic patients

Zheng-Wen He1, Jian Qu2, Ying Zhang3

  • 1Department of Neurosurgery, the Affiliated Cancer Hospital of Xiangya School of Medicine, Central South University, Changsha 410014, China. hezhengw@gmail.com.

Insights

Mutations in the proline-rich transmembrane protein 2 (PRRT2) gene are linked to various epilepsy syndromes, including febrile seizures. This research identifies PRRT2 mutations in 18.4% of patients with febrile seizures, suggesting a potential therapeutic target.

Area of Science:

  • Genetics
  • Neurology
  • Molecular Biology

Background:

  • The proline-rich transmembrane protein 2 (PRRT2) gene is associated with paroxysmal kinesigenic dyskinesia (PKD) and related epilepsy syndromes.
  • Previous research has established PRRT2 mutations in conditions like infantile convulsions with PKD and benign familial infantile epilepsy (BFIE).

Purpose of the Study:

  • To investigate the role of PRRT2 mutations in the etiology of febrile seizures, including febrile seizures plus (FS+), generalized epilepsy with febrile seizures plus (GEFS+), and Dravet syndrome (DS).
  • To explore PRRT2 as a potential drug target for personalized medicine in febrile seizure patients.

Main Methods:

  • Screening of PRRT2 exons in a cohort of 136 epileptic patients diagnosed with febrile seizures (FS+, GEFS+, DS).
  • Identification and characterization of PRRT2 genetic mutations using molecular screening techniques.

Main Results:

  • PRRT2 mutations were identified in 25 out of 136 (18.4%) patients with febrile seizures.
  • Five distinct mutations were identified: c.649delC (p.R217Efs*12), c.649_650insC (p.R217Pfs*8), c.412C>G (p.Pro138Ala), c.439G>C (p.Asp147His), and c.623C>A (p.Ser208Tyr).
  • These mutations included both loss-of-function and coding missense variants.

Conclusions:

  • PRRT2 variants are likely implicated in the pathogenesis of febrile seizures in epileptic patients.
  • The findings suggest PRRT2 as a significant genetic factor in febrile seizure disorders.
  • This study supports the potential of targeting PRRT2 for novel therapeutic strategies in epilepsy management.

Related Concept Videos

Epilepsy and Seizures: Overview01:24

Epilepsy and Seizures: Overview

Epilepsy is a chronic neurological disease marked by recurrent, unpredictable seizures. These seizures are caused by abnormal electrical discharges in the brain, leading to behavior, sensation, or consciousness alterations. They can also cause transient impairment of awareness, interfering with daily activities.
Various factors can trigger epilepsy, including genetic factors, brain damage, metabolic causes, and unknown etiology. Diagnosis of epilepsy involves electroencephalography (EEG), which...
1.8K
Seizures l: Introduction01:20

Seizures l: Introduction

Understanding seizures and epilepsy relies on key definitions that help in recognizing, classifying, and managing these disorders. These definitions provide a framework for recognizing, classifying, and managing seizure disorders.DefinitionsA seizure is a sudden, abnormal burst of electrical activity in the brain that can cause changes in awareness, movement, sensation, or behavior, depending on the area involved. Epilepsy is a chronic condition characterized by recurrent, unprovoked seizures,...
8
Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein01:20

Antiepileptic Drugs: Modulators of Neurotransmitter Release Mediated by SV2A Protein

Antiepileptic drugs, such as levetiracetam (Keppra) and brivaracetam (Briviact), have emerged as crucial tools in managing epilepsy. These medications exert their therapeutic effects by targeting the synaptic vesicle protein SV2A, a transmembrane glycoprotein primarily found in the brain.
SV2A is a transmembrane glycoprotein located predominantly in the brain, modulating the release of neurotransmitters for neuronal communication. Both levetiracetam and brivaracetam exhibit a high affinity for...
1.2K
Epilepsy ll: Types01:22

Epilepsy ll: Types

Recurrent seizures, stemming from abnormal electrical activity in the brain, are the defining characteristic of epilepsy, a chronic neurological condition. Because seizure features vary greatly, epilepsy is classified using two systems: by seizure type and by epilepsy syndromes. These classifications enable clinicians to describe seizure patterns and select suitable treatment strategies.I. Classification by Seizure Type1. Focal EpilepsyFocal epilepsy begins in one hemisphere of the brain.
15
Seizures: Classification01:13

Seizures: Classification

Epilepsy is primarily characterized by unpredictable seizures, either provoked by an identifiable factor, such as injury or illness, or unprovoked, occurring spontaneously without apparent cause.
Seizures are typically classified into two main categories: focal and generalized seizures.
Focal Seizures
Focal seizures originate from specific regions of the brain. These seizures are further sub-classified into two types:
2.5K
Seizures ll: Types01:19

Seizures ll: Types

Seizures are sudden bursts of abnormal electrical discharge in the brain that interfere with normal function. They are commonly divided into three groups: focal seizures, generalized seizures, and other types that do not fit neatly into either category.Focal SeizuresFocal seizures begin in a single brain region. When awareness is preserved, they are called focal aware seizures and may cause sensations such as tingling, unusual smells, or flashing lights. When awareness is impaired, they are...
12